A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Unresectable Breast Cancer
Interventions: DRUG: Letrozole|DRUG: Palbociclib|DRUG: Onapristone ER
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Context Therapeutics Inc.